Long COVID study using PET/CT scans
Part of Infections, Lungs & breathing clinical trials.
This study uses special imaging (PET/CT) to understand ongoing breathing problems or tiredness after COVID-19. It aims to learn how inflammation and changes in the body connect to symptoms that last more than 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have ongoing shortness of breath or tiredness for more than 3 months after a confirmed COVID-19 infection.
- You must have had a positive PCR test, a positive antibody test, or a high COVID-19 score on a CT scan when you were sick.
- You must be able to lie still on your back for the PET/CT scan (about 30–60 minutes).
- You cannot be pregnant or currently breastfeeding.
- You must agree to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.
This study checks on people who had covid-19 and still had symptoms months later. It aims to see how these long-term symptoms change over five years and what health challenges remain.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
Hear when a new PASC Post Acute Sequelae of COVID 19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.